Interleukin-1β rs1143627 polymorphism with susceptibility to periodontal disease

Oncotarget. 2017 May 9;8(19):31406-31414. doi: 10.18632/oncotarget.15612.

Abstract

Association between interleukin-1 beta (IL-1β) rs1143627 polymorphism and periodontal disease susceptibility was inconsistent; hence we performed this meta-analysis to explore the precise correlation between them. The degree of association was appraised through calculating pooled odds ratio (OR) and its 95% confidence interval (CI). The databases known as PubMed, Embase, and Chinese National Knowledge Infrastructure were searched up to October 26, 2016. A total of 8 eligible case-control studies were finally included, which involved 229 aggressive periodontitis patients, 382 chronic periodontitis patients, and 555 healthy controls. All the five genetic models revealed a non-significant association between IL-1β rs1143627 polymorphism and periodontal disease susceptibility (TT vs. CC: OR = 1.22, 95% CI = 0.80-1.87; CT+TT vs. CC: OR = 0.66, 95% CI = 0.44-1.01; TT vs. CT + CC: OR = 1.19, 95% CI = 0.81-1.74; T vs. C: OR = 0.92, 95% CI = 0.81-1.12; CT vs. CC: OR = 0.92, 95% CI = 0.69-1.23). Sensitivity analyses indicated that the results were robust and the subgroup analyses reached similar conclusions. IL-1β rs1143627 polymorphism is not related to periodontal disease susceptibility in the overall population based on the current evidence, but further studies are required in more large scale sample size with risk factor adjusted.

Keywords: interleukin-1; meta-analysis; periodontal disease; periodontitis; polymorphism.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Alleles*
  • Case-Control Studies
  • Genetic Association Studies*
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Interleukin-1beta / genetics*
  • Odds Ratio
  • Periodontal Diseases / genetics*
  • Polymorphism, Single Nucleotide*
  • Publication Bias

Substances

  • Interleukin-1beta